Concepedia

Madeline Jenkins

MJ

3

Publications

78

Citations

3

H-Index

2019

Active since

Affiliations

Institute of Group Analysis(Current)

Analysis Group (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

MSD (Netherlands)

Madeline Jenkins is an author at Institute of Group Analysis specializing in rehabilitation, exercise physiology, and physical fitness.

Top concepts

Publications per year

2019–2020

3

Publications

3

Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration

Nathalie Goemans, Brenda Wong, M. van den Hauwe et al. · PLoS ONE · 2020 · 34 citations · Full text

, , +18

Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States

Arielle G. Bensimon, Zheng‐Yi Zhou, Madeline Jenkins et al. · Journal of Medical Economics · 2019 · 27 citations · Full text

An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA

Arielle G. Bensimon, Zheng‐Yi Zhou, Madeline Jenkins et al. · Clinical Drug Investigation · 2020 · 17 citations · Full text

Rows per page

1–3 of 3